Ultra-low dose estriol vaginal gel (0.005%, 0.002%, 0.0008% Estriol Vaginal Gel)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ultra-low dose estriol vaginal gel (0.005%, 0.002%, 0.0008% Estriol Vaginal Gel), covering 2019-09-25 to 2019-09-25. Get the full timeline:
Most recent: Clinical Trial Update: Study Evaluating the Efficacy and Safety of Three Formulations of Ultra-low Dose Estriol Vaginal Gel (0.005%, 0.002%, 0.0008% Estriol Vaginal Gel) for the Treatment of Vaginal Dryness in Postmenopausal Women With Vulvovaginal Atrophy [Phase 2]